Literature DB >> 723799

Alpha-hemolytic streptococci: clinical significance in the cancer patient.

P A Pizzo, S Ladisch, F G Witebsky.   

Abstract

Alpha-hemolytic Streptococci were associated with 29 episodes of sepsis (12 polymicrobial) in 27 patients with cancer during a nine year period. Only two patients had dental manipulation prior to the onset of sepsis, but each had received chemotherapy and 75% were granulocytopenic (PMN less than 500/mm3) at the time of the infection. None of the patients developed bacterial endocarditis. Unlike the normal host in whom a transient bacteria with alpha-hemolytic Streptococci may occur following dental extraction or periodontal procedures, the cancer patient is at risk for more clinically significant sepsis. This risk is probably related to the presence of chemotherapy-induced oral mucusitis and granulocytopenia, and our results suggests that isolation of alpha-hemolytic Streptococci in febrile cancer patients should not be dismissed as a contaminent.

Entities:  

Mesh:

Year:  1978        PMID: 723799     DOI: 10.1002/mpo.2950040414

Source DB:  PubMed          Journal:  Med Pediatr Oncol        ISSN: 0098-1532


  9 in total

1.  Febrile neutropenic events in cancer patients: treatment for fever and neutropenia in young adult patients during intensive chemotherapy for solid tumours.

Authors:  M Nobbenhuis; F J Cleton
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

2.  Randomized trial of the addition of gram-positive prophylaxis to standard antimicrobial prophylaxis for patients undergoing autologous bone marrow transplantation.

Authors:  E R Broun; J L Wheat; P H Kneebone; K Sundblad; R A Hromas; G Tricot
Journal:  Antimicrob Agents Chemother       Date:  1994-03       Impact factor: 5.191

3.  Prevention of viridans-group streptococcal septicemia in oncohematologic patients: a controlled comparative study on the effect of penicillin G and cotrimoxazole.

Authors:  H F Guiot; J W van der Meer; P J van den Broek; R Willemze; R van Furth
Journal:  Ann Hematol       Date:  1992-06       Impact factor: 3.673

4.  Isolation of vancomycin-resistant enterococci in haematologic patients.

Authors:  H F Guiot; W E Peetermans; F W Sebens
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-01       Impact factor: 3.267

5.  Respiratory failure elicited by streptococcal septicaemia in patients treated with cytosine arabinoside, and its prevention by penicillin.

Authors:  H F Guiot; W G Peters; P J van den Broek; J W van der Meer; J A Kramps; R Willemze; R van Furth
Journal:  Infection       Date:  1990 May-Jun       Impact factor: 3.553

6.  Prevalence of penicillin-resistant viridans streptococci in healthy children and in patients with malignant haematological disorders.

Authors:  H F Guiot; L J Corel; J M Vossen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-08       Impact factor: 3.267

7.  Defining antibody targets in Streptococcus oralis infection.

Authors:  J P Burnie; W Brooks; M Donohoe; S Hodgetts; A al-Ghamdi; R C Matthews
Journal:  Infect Immun       Date:  1996-05       Impact factor: 3.441

8.  Streptococcus mitis strains causing severe clinical disease in cancer patients.

Authors:  Samuel A Shelburne; Pranoti Sahasrabhojane; Miguel Saldana; Hui Yao; Xiaoping Su; Nicola Horstmann; Erika Thompson; Anthony R Flores
Journal:  Emerg Infect Dis       Date:  2014-05       Impact factor: 6.883

9.  Epidemiology and clinical features of bloodstream infections in hematology wards: one year experience at the catholic blood and marrow transplantation center.

Authors:  Jae-Cheol Kwon; Si-Hyun Kim; Jae-Ki Choi; Sung-Yeon Cho; Yeon-Joon Park; Sun Hee Park; Su-Mi Choi; Dong-Gun Lee; Jung-Hyun Choi; Jin-Hong Yoo
Journal:  Infect Chemother       Date:  2013-03-29
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.